home / stock / mdwd / mdwd news

MDWD News and Press, MediWound Ltd. From 03/14/24

Stock Information
Company Name: MediWound Ltd.
Stock Symbol: MDWD
Market: NASDAQ
Website: mediwound.com
Menu
MDWD MDWD Quote MDWD Short MDWD News MDWD Articles MDWD Message Board
Get MDWD Alerts

News, Short Squeeze, Breakout and More Instantly...
MDWD - MediWound to Report Fourth Quarter and Full Year 2023 Financial Results

YAVNE, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced that the Company will release its financial results for the fourth quarter and full year ended December 31, 2023 on Thurs...
MDWD - MediWound stock climbs 9% on Phase 2 data for wound care treatment

2024-02-12 12:19:10 ET More on MediWound MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript FDA accepts MediWound application for NexoBrid pediatric approval MediWound wins DoD funding to develop NexoBrid for U.S. Army Seeking Alpha’s Quant Rating ...

MDWD - MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

YAVNE, Israel, Feb. 12, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair today announced the results of head-to-head comparison analyses of EscharEx, the Company’s lead asset in development for chronic wou...

MDWD - How the (MDWD) price action is used to our Advantage

2024-02-11 02:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MDWD - MediWound to Participate in Two Upcoming Investor Conferences

YAVNE, Israel, Feb. 05, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced its participation in the upcoming Oppenheimer 34 th Annual Life Sciences Conference...

MDWD - (MDWD) Investment Report

2024-01-31 10:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MDWD - (MDWD) Technical Pivots with Risk Controls

2024-01-20 12:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MDWD - FDA accepts MediWound application for NexoBrid pediatric approval

2024-01-09 11:44:56 ET More on MediWound MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript MediWound wins DoD funding to develop NexoBrid for U.S. Army Seeking Alpha’s Quant Rating on MediWound Historical earnings data for MediWound Financ...

MDWD - MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns

If approved, NexoBrid will serve as an effective non-surgical treatment for both pediatric and adult burn patients in the U.S. NexoBrid is already approved for use for burn patients across all age groups in Europe and Japan YAVNE, Israel, Jan. 09, 2024 (GLOBE NEWSWIRE) -- MediWo...

MDWD - MediWound wins DoD funding to develop NexoBrid for U.S. Army

2023-12-28 07:20:44 ET More on MediWound, Vericel, etc. MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript Vericel Corporation 2023 Q3 - Results - Earnings Call Presentation 3M to join MediWound ...
Previous 10 Next 10